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INTRODUCTION
Urinary tract infection is the most common
nosocomial infection and also is second common
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ABSTRACT
Urinary tract infection has change a basic challenge in human population. Antibacterial
nanoparticles have turned over the new leaf in scientist’s research.Ag/ZnOnanoparticleis synthesis
in high temperature (5000C).FT-IR, XRD, SEM and TEM were used for determination of
spectroscopic, structural and morphology of samples, respectively. Also the nanoparticlewas
digested and analyzed by ICP-AES for determining the presence of residual chemical element in
the nanoparticle. Bacterial sensitivity to nanoparticlewas commonly tested using by MIC and MBC
tests. For achievement of in vivo tests, the renal of rats were injectedand then were infected with
E.coli. After that, animals were divided to 9 treatment groupand the effect of three concentrations
of MICandMBC; also intermediate concentrations of MICandMBC and each as a separate group,
were studied.The particles size was less of 12nm, approximately. The MIC and MBC observed for
Ag/ZnOwere 32µgml-1and 512µgml-1 for E.coli, respectively.Treatment with a concentration 512µgml-
1ofAg/ZnO nanoparticle in combination with Ciprofloxacin reduced severity of renal cortical thickness
of pyelonephritis rats.The microscopic pathological examination indicated that there was no any
severe Inflammation of renal tubules in the groups that had been treated with512µgml-1concentration
of Ag/ZnO nanoparticlein combination with ciprofloxacin.In compared with the control groups.This
study showed thatthe Ag/ZnO nanoparticle in cooperation with ciprofloxacin has great antimicrobial
effect againstE.coli on renal damage of Pyelonephritis.
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infection in the human population so that each year
more than 7 million patients visit physicians’ offices
in the United States of America. The infection can
be seen in 1 to 3 percent of school-aged girls and
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in 2 to 8 percent of pregnant women. Researches
show that all women in their lifetime will experience
a UTI turnand almost 25 percent of women in their
lifetime, once are affected by symptomatic severe
urinary tract infections1,2. Urinary tract infection
according to infection part is divided into types of
urethritis, pyelonephritis which pyelonephritis is the
more dangerous type among other and has serious
complications, especially in the area of   childhood
which is diagnosed Based on urine3,4,5 and urinary
symptoms such as dysuria, urinary frequency, flank
pain and fever6. According to research carried out
by Wales, the most common pathogen isolated from
urine, was reported E.coli7. Late Diagnosis and
treatment lead to irreversible renal injury in patients
with pyelonephritis and one of the most risky results
of pyelonephritis is the formation of these renal
scars8. This phenomenon is mainly due to
inflammatory damage is caused by a bacterial
infection. Since early diagnosis and antibiotic
treatment in these cases is often delayed, there is
the possibility of developing renal scars in more
than 40 percent of those with high blood pressure,
urinary protein excretion, and renal diseases9. On
the other hand, due to the increasing incidence of
resistance of microorganisms to beta-lactam and
aminoglycoside antibiotics, which causes their
efficiency to be reduced, Also consider the potential
side effects of each drug, several researchers has
been done to find alternative antibacterial agents
in the case of urinary tract infection10. Hence
antibacterial properties of Nano metal oxides have
been discovered as new generation of antimicrobial
agent and researchers have offered the use of silver
and zinc ions as superior disinfectants for from
hospitals infectious microorganisms11,12,13. Although,
they have believed that residual these metal ions
may adversely affect human health14 but scientist
experiments demonstrated selectivity in the toxic
nature of ZnOnanoparticleto different bacterial
systems and human T lymphocytes.As far as today,
researchers havefocused on the production of ZnO
nanoparticles using the aqueousroot extracts of
Zingiber officinale15.Those results suggested that
ZnOnanoparticlemay potentially prove useful as
Nano-medicine based antimicrobial agents at
selective therapeutic dosing regimens11.The
mechanism of action of the silver and zinc
nanoparticles is not yet fully established11,16. But
nowadays, we know that the bactericidal effect of
metal nanoparticlehas been attributed to their small
size, photo-catalystic of activity and high surface to
volume ratio, which allows them to interact closely
with microbial membranes and is not merely due to
the release of metal ions in solution17. While various
hypotheses have been proposed to explain the
mechanism of antimicrobial activity of silver
nanoparticle, it is widely believed that silver
nanoparticle is incorporated in the cell membrane,
which causes leakage of intracellular substances
and eventually causes cell death18,19. Some of the
silver nanoparticle also penetrate into the cells. It is
also reported that bactericidal efficiency is affected
by the type of microorganism. In studies with gram
negative, E.coli; Kim reported greater biocide
efficiency of silver nanoparticle for E.coli20. Also
recently, Jayesh assumed that combination of metal
oxide nanoparticle may give rise to more complete
bactericidal effect against mixed bacterial
population 16. The Purpose of this study was
synthesis of ZnO and Ag nanoparticles
monometallic and Ag/ZnOnanoparticle via thermal
decomposition of oxalate precursor method. The aim
of this study was to investigate the antibacterial
effects of Ag/ZnOnanoparticle on renal scars due to
pyelonephritisrenal infection in rat models.
MATERIALS AND METHODS
Synthesis of Ag/ZnONanoparticle and
Characterization
Ag/ZnOnanoparticle was synthesized in
Antimicrobial resistance research center of Iran
University of medical science, according to Jafari
and their Colleague’s protocol.Crystallinity of the
nanoparticle performed using an X-ray diffract-o-
meter set (XRD, Bruker D8-Advance diffract meter
using Cu Kα radiation). The nanoparticle was
analyzed by inductively coupled plasma-atomic
emission spectroscopy (ICP-AES, LIBERTY–RL,
Varian Australia Co.) FT-IR spectra was recorded
on a Bruker spectrophotometer in KBr pellets.
Surface morphology of product was characterized
by using a scanning electronic microscopy (SEM,
Cam Scan MV2300) with an accelerating voltage
of 30 KVand Transmission electron microscopy
(TEM)21,22
.
Antibacterial tests
According to research conducted, the
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lowest concentration of material that inhibits the
growth an organism was defined as the MIC. From
the serial dilution method, was employed to
determine the MIC of the nanoparticles21,22. The
microbial growth was studied by turbid metric
measurement, using a spectrophotometer (Nano-
volumespectrophotometer, Scandrop 250,
Analyticjena Co.)23. All the experiments were carried
out on triplicate. MBC, that is, the lowest
concentration of nanoparticle that kills 99.9% of the
bacteria was also determined from the batch culture
studies. To experiments for bactericidal effect,
loopfull from each test tube was inoculated on
Muller Hinton agar and incubated at 35°C for 24 h.
The release of Ag+ and Zn2+ ions from the
nanoparticle into DI water and Muller Hinton Broth
medium was deliberated. And also residual Ag+ and
Zn2+ concentration in the aqueous phase was
definite by ICP-AES after 24 h.
Maintenance Condition of Rat model
Random bred male Wistarrats weighing
approximately 130±10 g, obtained from
TarbiatMoallem University of Karaj laboratory,
Laboratory Animal of Reproduce Center, Karaj, Iran.
The rats were evaluated prior to initiation of the
study to ensure a sanitary hygienic condition and
acclimation to the study environment. Clinically
accepted animals were randomly assigned into
nine major groups and in each group were 5 rats (5
rats/group).
Environmental Condition of Rat Model
A total of 45 rats, were housed in stainless
steel wire mesh cages on a bedding of wood chips
(Five animals/Cage). They were kept in an ambient
temperature of 22 ± 2oC, with 40-60% air moisture
on a light/dark cycle of 12/12 hours and supplied
rat chow (the diet) and fresh water.
Bacterial Strains
The bacterial strain of E.coli used in this
project was (ATCC25922) which certainty was
pathogen and disease-causing in rats and it
absolutely caused APN in them.
Surgery and injection of bacterial suspension
At First, The 4:1 ratio of the two drugs
Ketamine Hydrochloride and Xylazinewas
Prepared and the 0.1 ml of it was injected into the
peritoneal of rats till they got anesthetized animals.
Then the left side of the rats (Between ribs and hip
bone) is sterilized with ethanol 70% (MERCK,
Germany) and longitudinal incision with the length
of 2 to 3 cm is created by surgical blade. After cutting
the skin and muscle layers below it, incision on
both sides with a special forceps kept open and
with an insulin syringe, the 0.3ml of bacterial
suspension with concentration of 1.5×108CFUml-1
microorganism, in two to three different regions of
the apical region of renal cortex is injected. Then
with the needle and suture the muscle layer and
the skin layer, sutures tied and diluted
povidonelodinetopical solution(DarooDarman,
10%) is used to disinfect the wound. During the
course of treatment the wound disinfected every
day and Washing with saline is given after surgery
to prevent infection.
Urine culture
Urine was collected from mice 24 hours
after surgery and In order to count the number of
colonies were cultured in EMB by Pure culture.
Antibiotic Sensitivity Test
To determine the sensitivity of standard
strain of E.coli to common antibiotics, Disc Diffusion
agartest with Ceftriaxone (30µg),Gentamicin
(10µg), Ciprofloxacin (5µg)andCefazolin (30µg),
antibiotic disks on Mueller Hinton agar medium
were done. After 24 hours of incubation, the
diameter of growth inhibition around each disc was
measured and compared. The disc which has the
maximum diameter of the inhibitory zone; it is more
effective to destroy bacteria.
Treatment
Curing the Treatment groups began
treatment 72 hours after surgery. Groups treated
with antibiotics received the ceftriaxone at a dose
of 50 mg/kg diluted with distilled water by
intramuscular injection. Drug treatment groups were
orally received Ag/ZnOnanoparticle as a
suspension in distilled water by gavage needle.
The experimental groups
In this study, the animals were divided into
9 groups and the effect of three concentrations of
MICandMBC tests; also intermediate
concentrations of Ag/ZnO nanoparticle between
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them, each as a separate group, were studied. Group
1: The control group which has false surgery (Non-
injected kidney infection) but the infection is not
transmitted and after 72 hours, daily and for 14 days
saline solution at a dose of 10 mg/kg was injected
into their peritoneum. Group 2: The group which
underwent surgery with transferring infection with
concentration of  1.5×108 CFU/ml and the infection
was transferred and After 72 hours, daily for 14 days
Normal Saline solution 0.9% (Darosazi-Samen,
Iran) with a dose of 10 mg/kg injected into the
peritoneum of this group. Group 3: The group which
underwent surgery and infection was transmitted
and after 72 hours for 14 days, only received the
ciprofloxacin antibiotic at a dose of 50 mg/kg by
intramuscular injection. Group 4: The group which
underwent surgery and infection was transmitted
and after 72 hours for 14 days, orally received 1 ml
Ag/ZnO nanoparticle with the concentration of
32µgml-1 (MIC). Group 5: The group which
underwent surgery and infection was transmitted
and after 72 hours for 14 days, orally received 1 ml
Ag/ZnO nanoparticles with a concentration of
32µgml-1 (MIC) also received ciprofloxacin antibiotic
concentration of 50mg/kg by intramuscular injection.
Group 6: The group which underwent surgery and
infection was transmitted and after 72 hours for 14
days, orally received 1 ml Ag/ZnO nanoparticles
with the concentration of 128 µgml-1(Concentration
between the MIC and MBC). Group 7:  The group
which underwent surgery and infection was
transmitted and after 72 hours for 14 days, orally
received 1 ml Ag/ZnO nanoparticles with the
concentration of 128 µgml-1(Concentration between
the MIC and MBC) also received the ciprofloxacin
antibiotic at a dose of 50 mg/kg by intramuscular
injection. Group 8: The group which underwent
surgery and infection was transmitted and after 72
hours for 14 days, orally received 1 ml Ag/ZnO
nanoparticle with the concentration of 512 µgml-1
(MBC). Group 9: The group which underwent surgery
and infection was transmitted and after 72 hours for
14 days, orally received 1 ml Ag/ZnO nanoparticle
with the concentration of 512µgml1 (Concentration
between the MIC and MBC) also received the
ciprofloxacin antibiotic at a dose of 50 mg/kg by
intramuscular injection.
Histological and Pathological examination of
kidney tissue
After 6 weeks, all animals were killed after
anesthesia and their kidneys removed and divided
longitudinally into two halves and In order to
investigate the histological and pathological
assessments fixed in 10% formaldehyde. Tissues
Obtained are strained by Hematoxylin and Eosin
(H&E)andMasson and Microscopic assessment
were done by a pathologist who is unaware of their
grouping. Finally, by comparing the data obtained
from each of the groups, the added effect of each
variable was examined.
RESULTS
The FT-IR spectra analysis
Fig.1. shows FT-IR spectra of Ag/ZnO
nanoparticle. Fig.1. conclude Ag/ZnO FT-IR
spectrum. The broad band at 3426.47 cm-1 was
allocated to both the νs (O-H) and νs (O-H) of
hydration water. The extreme band at 1628.14 cm-1
was allocated to asymmetric and water tensional
tremble δ (H-O-H). The shoulder at 1458.22 cm-1 is
Fig. 1: FT-IR spectra of Ag/ZnO nanoparticle
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present in the spectrum evidence of (N-O) tremble
and the closely spaced bands 625.36 cm-1 are
presents in the spectrum evidence of (Ag/ZnO)
tensional tremble, respectively.
The XRD spectra analysis
The XRD pattern of Ag/ZnO nanoparticle
(Fig. 2.) was compared and interpreted with
standard data of International Centre of Diffraction
Data (ICDD). The average crystallite size (C.S) of
the nanocrystale was calculated using the Debye-
Scherer Equation from the major diffraction peaks.
The average crystallite size of the Ag/ZnO was
12.15 nm.
The ICP-AES spectra analysis
By ICP-AES analysis, we succeed to
estimation of residual ions, after digestion of
nanoparticle by sonication. They indicated ions
levels of 120 ppm to silver and d” 1 ppm to zinc
oxide, in the silver/Zinc Oxide nanoparticle,
respectively.
The TEM and SEM images analysis
TEM image (Fig. 3.) of nanoparticle
approved that the metal particles was in the Nano
range, approximately. However, SEM images (Fig.
4.) of nanoparticle was showed that Ag/ZnO metal
particle was exactly in the shape of spherical and
cluster.
Fig. 2: The XRD pattern of Ag/ZnO nanoparticle
Fig. 3: TEM image of Ag/ZnO nanoparticle Fig. 4: SEM image of Ag/ZnO nanoparticle
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The antibacterial activity analysis
The results in depended of the
antibacterial effects of nanoparticle against E.coli
via MIC and MBC are summarized in Table 1. A
greater lag phase and lower maximum absorbance
(at 600 nm) were observed as the concentration of
nanoparticles increased. Similar observation was
reported by Sondi and Salopek-Sondi19. We had
analyzed effectively of silver/zinc oxide nanoparticle
against E.coli. The bactericidal effect of nanoparticle
is dependent on the concentration of nanoparticle
and the initial bacterial concentration24. In this study,
the initial bacterial concentration was constant at
1.5×108 CFU ml-1 regardless of nanoparticle
concentration and microbial strain. Our research
shows that the silver/zinc oxide nanoparticle has
great antibacterial effect against E.coli. In fact, the
E.coli was most sensitivity against of silver/zinc oxide
nanoparticle. The MIC and MBC observed in this
study for silver/zinc oxide nanoparticle were 32
µgml-1 and 512 µgml-1 for E.coli, respectively.Study
of renal glomerulus pyelonephritis in mice treated
with Ag/ZnO Nanoparticle Compared with other
experimental groups
The results show that the number of renal
glomeruli, also the kidney glomerular diameter in
sham pyelonephritis rats and rats treated with
concentration of 32 µgml-1 Ag/ZnO Nanoparticle
(Group 4) Compared with normal rats in the control
group, have a significant reduction.  While the other
groups, reducing the number of objects does not
Fig. 5: Cortical and central sections of the adult male wistar rat kidneys belong to
control group (A), sham (B), Antibiotic (C), Group 1 (D), Group 2 (E),
Group 3 (F), Group 4 (G), Group 5 (H), Group 6 (I) (hematoxylin-eosin, × 400)
*Group 1: Ag/ZnO Nanoparticle (32µgml-1), Group 2: Ag/ZnO Nanoparticle (32µgml-1) + Antibiotic (Ciprofloxacin),
Group 3: Ag/ZnO Nanoparticle (128µgml-1), Group 4: Ag/ZnO Nanoparticle (128µgml-1) + Antibiotic (Ciprofloxacin),
Group 5: Ag/ZnO Nanoparticle (512 µgml-1), Group 6: Ag/ZnO Nanoparticle (512 µgml-1) + Antibiotic (Ciprofloxacin)
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show a significant difference compared to control
group. The results show that the thickness of the
cortical kidney in pyelonephritis rats of sham group
and also, rats treated with concentrations of 32
µgml-1 and 128 µgml-1Ag/ZnO nanoparticle
Compared with normal rats in the control group
decreased significantly. While treatment with a
concentration of 512 µgml-1Ag/ZnO nanoparticle
and also antibiotic treatment in separate groups
and treated groups with the concentration of 512
µgml-1reduced Severity of renal cortical thickness
of pyelonephritis rats in these groups compared to
sham rats and reduce the number of objects in this
group than in the control group did not show
significant differences.
Microscopic study of sections of kidney tissue
Tissue slides prepared from the
experimental group, encoded and given to the
expert pathologist who was unaware of the
characteristics of the experimental group and order
of slides so that Check the status of their tissue of
various pathological factors and reports them. For
this aim, complications such as Inflammation of the
tissue, dilated and Dilated Tubules, Atrophic
Tubules, Neutrophil Abscesses, Tubular damage,
Tissue Necrosis, Apoptotic injury, PMN within the
tubular, Cast within the context were pathologically
scrutinized. The microscopic pathological
examination was performed on sections prepared
from groups of data in this study also identified areas
of tissue damage that is shown in Table 2.
Inflammation of renal tubules is the most
importance indicators of kidney tissue pathology of
pyelonephritis and the results suggest that indicate
severe inflammation occurred in the sham group
and there was the difference compared to the control
group. However in the treated group by ciprofloxacin
antibiotic and also the groups treated with different
concentration of Ag/ZnO nanoparticle, especially
the 128 µgml-1 and 512 µgml-1, as well as additional
particles treated with antibiotics, it is quite evident.
Urine culture
The results of this study show that injection
of 0.1 ml of bacterial suspension of E.coli ATCC
25922 strain which has a 0.5 McFarland standard
bacterial concentration to various areas of the poles
of the kidney cortex of rats causes the pyelonephritis
Kidney infection model to be created in them. So
that, causing infection in the kidneys of rats with
urine culture in respective rats and bacterial growth
in EMB medium and creating green shiny color of
colonies, which is the unique characteristics of the
bacteria colonies in this medium, clearly was
evidenced.
Fig. 6: Urine culture of sham group (Left) and
control group (Right) on EMB medium
DISCUSSION
Jayesh performed extensive experiments
in determination of microbial sensitivity of various
bacteria to silver and copper nanoparticles, using
disc diffusion method16. Regarding that the diameter
of inhibition zone (DIZ), reflects the sensitivity of
the organism, strains of sensitive, show larger DIZ
and the resistant strains show smaller DIZ. Results
of the disc diffusion with Ag nanoparticle, by
Thirumurugan against strains of pathogens E.coli,
indicated higher sensitivity to silver nanoparticles
which is in contrast with the results of our study24.
The E.coli, used in the current study, showed the
least and the most sensitivity to silver and Ag/ZnO
nanoparticles, respectively. Actually, the least
degree of MIC in E.coli was related to combined
nanoparticles of silver and zinc with concentration
of 128 µgml-1. i.e, notwithstanding this nanoparticle
had the most growth inhibitory effect in E.coli. Kim
studied the gram negative bacteria E.coli, also
reported that the antibacterial silver nanoparticle
mostly affects the E.coli, which is due to the
difference between cell wall of gram negative
microorganism20. Limited studies performed on the
antibacterial properties of ZnO nanoparticle. Reddy
were amongst few authors worked on the toxicity of
the ZnO nanoparticle in gram negative bacteria 11.
They found that nanoparticles are able to completely
inhibit the growth of E.coli. Ling Yang and jafari
combined silver nanoparticles with Zn to improve
antibacterial activity of Zn nanoparticle and
investigate the antibacterial effect of Zinc oxide and
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silver nanoparticles and also comparing them with
Ag/ZnO nanoparticle 25,21. They obtained interesting
results. According to the findings of Kawashita and
Pak-soo silver significantly increased antimicrobial
activity 26,27. Actually, Ling Yang believed that photo-
catalytic ability of ZnO nanoparticle plus silver
nanoparticle improves and also increases its
oxidation and reduction abilities, while suppressing
bacteria growth28,29. However, silver ions, eventually
release during sterilization and kill bacteria due to
their high antibacterial activation. They theorized
that silver ions release following bacteria death and
colloid with other bacteria and repeat their
sterilization behavior.  It was also mentioned that
silver covered in the surface of Zn nanoparticle has
the ability to involve the electrons produced through
photo-catalytic reactions of Zn nanoparticle which
increases electron isolation and makes gaps in cell
membrane, so increase its antimicrobial activity.
Regarding studies of these authors, antibacterial
property of silver and zinc oxide nanoparticles
improves with their combination. Up to now, no
complete and comprehensive study reported in the
field of antibacterial properties of Ag/ZnO for
E.colion Renal Damage in Rat Model of
Pyelonephritis.Our study confirmed that the gram
negative strains of bacteria, specifically E.coli; had
most sensitive to silver/zinc oxide nanoparticle. In
addition, out study approved thatinflammation is
suppressed after completion of treatment via Ag/
ZnO nanoparticle in combination with Ciprofloxacin.
In fact, inhibition of tissue inflammation in the group
which was treated with Ag/ZnO nanoparticle in
combination with Ciprofloxacin after getting a
urinary tract infection and pyelonephritis could
indicate that the concentration of particles in the
well can act as anti-inflammatory substance and
reduced severity of inflammatory tubule which is
the main characteristic of pyelonephritis kidney.
Pathological studies on other indicators such as
tubular dilation, Neutrophil abscesses, Atrophy,
Necrosis and Tubular damage was also having the
same situation. In fact, it reflects the influence of Ag/
ZnOnanoparticles on renal tissue and increase
protection of renal tissue against pyelonephritis
infection. According to the research done, Ag/ZnO
nanoparticle in cooperation with ciprofloxacin had
great antimicrobial effect against E.coli (ATCC
25922) on renal damage of Pyelonephritis.
Interesting point was here that in microscopic
pathological examination, there was no any severe
Inflammation of renal tubules in the groups that had
been treated with MBC concentration of Ag/ZnO
nanoparticle in cooperation with ciprofloxacin and
treatment with that, reduced severity of renal cortical
thickness of pyelonephritis rats.
ACKNOWLEDGEMENTS
We are indebted to research Vice
Chancellor of Iran University of Medical Sciences,
for supporting this research. Also, we gratefully
acknowledge to University of Industrial Sahand,
Tabriz, Department of Nanotechnology, for the XRD
and SEM analysis. The authors would like to
acknowledge to Iranian Mineral Processing
Research Center (IMPRC) for ICP-AES analysis,
TarbiatMoallem University and Laboratory Animal
of Reproduce Center, Karaj, Iran. We gratefully
acknowledge Executive Director of Iran-
Nanotechnology Organization (Govt. of Iran) and
pathological laboratory of Dr. Alireza Vahab-zade.
The anonymous reviewers are acknowledged for
providing valuable comments and insights for
improving the manuscript.
REFERENCES
1. Rahul, M.;Sudhir, A.;Saroj, Sh.; Sanjay,
Ch.;Kusum, H. Journal of Infection and Public
Health .2009; 2: 101-111
2. Shirishkumar, P.;Pankajkumar, P. T.; Mala,
S.;Javadekar,T. B.;Vipul, P. Ch.National
Journal of Community Medicine.2012, 3,
138-141
3. Heller, E.D.;Drabkin,N. British Veterinary
J.1977, 133, 572-578
4. Duguid, J. P.; Cleggs.;Wilson,I. J. Medical
Microbiol.1979, 12, 213-217
5. Bauer, A.W.; Kirby, W.M.M.; Sheris, J.C.; Truck,
M. American J. Clinical Pathol.1966, 142,
225-230
6. Reddy,K.;Koteeswaran,Y. A. Indian Veterinary
J.1994, 71, 959-963
1445KHOSHKBEJARI et al., Orient. J. Chem.,  Vol. 31(3), 1437-1445 (2015)
7. Yoder, H.W.Avian Diseases.1989, 33, 502-
505
8. Roy, P.;Edwin,P.G.;Purushothaman,V. Indian
Veterinary J.2004, 81, 1317-1320
9. Susantha, M.G.; Riddell, C.; Andrew, A.P.;
Allan, B.J. Canadian Journal of Veterinary
Res. 2001,  65, 1-6
10. Reddy,K.;Koteeswaran,Y. A.;Dorairajan,N.
Indian Veterinary J.1994, 71, 209-212
11. Reddy, k.; Bell, J.;Wingett, D.; Hanley,
C.;Punnoosea, A.Appl. Phys.Lett. 2007, 24,
90-93
12. Lin, YE.;Vidic, R.D.; Stout, J. E.;Mccartney, C.
A.; Yu, VL.Water Res.1998, 32, 1997–2000
13. Lin,YE.;Vidic, RD.; Stout, JE.; Yu, VL.Water
Res. 1996, 30, 1905–1913
14. Blanc,DS.;Carrara, P.;Zanetti, G.;Francioli,
P.J. Hosp. Infect.2005, 60, 69–72
15. Anand Raj, L.F.A;Jayalakshmy, E.Oriental
Journal of Chemistry.2015, 31, 51-56
16. Jayesh, P.; Arup K. Ch.; Siddhartha,
P.;Duttagupta,;Suparna, M. Nanomedicine.
2007, 3, 95–101
17. Morones, J. R.;Elechiguerra, J.L.; Camacho,
A.; Holt, K.;Kouri, J.B.; Ramirez,
J.T.Nanotechnology.2005, 16, 2346–2353
18. Cho, K.; Park, J.; Osaka, T.; Park, S.
Electrochim. Acta. 2005, 51, 956–960
19. Sondi, I.;Salopek, S. B.J. Colloid Interf. Sci.
2004, 275, 177–182
20. Kim, J. S.;Kuk, E.; Yu, K. N.; Kim, J. H.; Park, S.
J.; Lee, H. F.; Kim, S. H.; Park, Y. K.; Hwang, C.
Y.; Kim, Y. K.; Lee, Y. S.;Jeong, D. H.; Cho, M. H.
Nanomedicine.2007, 3, 95–101
21. Jafari, A.;Ghane, M.;Arastoo, sh.African
Journal of Microbiology Research.2011, 30,
5465-5473
22. Jafari, A.; Ghane, M.; Sarabi, M.; Siyavoshifar,
F.Oriental Journal of Chemistry.2011, 27,
811-822
23. Case, C. L.; Johnson, T. R.California,
Benjamin Cummings Pub Inc.1984, 126–
129
24. Dabbagh, M. A.;Moghimipour, E.;Ameri,
A.;Sayfoddin, N.Iranian.2008, 7, 21-28
25. Siva, K. V.;Nagaraja, B. M.;Shashikala,
V.;Padmasri, A. H.;Madhavendra, S. S.;Raju,
B. D.J MolCatal A Chem.2004, 223-313
26. Williams, D. N.;Ehrman, SH.;Holoman, TRP.J
Nanobiotechnol.2006, 4-3
27. Kawashita, M.;Tsuneyama, S.; Miyaji,
F.Biomaterials.2000, 21, 393-398
28. Pak, S. J.; Jang, Y.Journal of Colloid and
Interface Science.2003, 261, 238-243
29. YANG, L.; MAO, J.; ZHANG, X.; XUE, T.; HOU,
T.; WANG, L.;Mingjing, T.U. Nanoscience.
2006, 11, 44-48
